Split and side-ported catheter devices
US-12156975-B2 · Dec 3, 2024 · US
US2019015584A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2019015584-A1 |
| Application number | US-201816134691-A |
| Country | US |
| Kind code | A1 |
| Filing date | Sep 18, 2018 |
| Priority date | Jul 7, 2015 |
| Publication date | Jan 17, 2019 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An apparatus and method for the aseptic delivery of a biologic medication in a wearable form factor. The apparatus and method allow for standard off-the-shelf drug cartridges to be utilized without compromising the sterility of the biologic. Further, by utilizing a two part assembly, manufacturing costs are minimized.
Opening claim text (preview).
1 . A method for subcutaneous drug delivery, the method comprising: pushing, by a patient, a start button; responsive to the pushing, concurrently: puncturing, by a fluid path needle integral to the start button, a sterile drug barrier of a sterile drug assembly and a septum of a drug container, wherein the drug container stores a sterile biologic; disengaging, by a declined ramp of the start button, a carrier arm of a carrier to trigger a primary spring of needle insertion mechanism to release stored potential energy; and contacting, by a triggering post integral to the start button, a sterile electronic barrier of the sterile drug assembly to activate a triggering switch of an electronic circuit board; responsive to the puncturing: establishing a fluid pathway from the drug container; responsive to the disengaging: moving the carrier and a needle hub assembly in a direction towards the patient, wherein the carrier and the needle hub assembly are coupled by release tabs; inserting a cannula of the carrier into the patient; uncoupling the carrier and the needle hub assembly by forcing the release tabs to contact separators; removing a needle of the needle hub assembly from the cannula by moving the needle hub assembly away from the patient using potential energy released by a secondary spring when the carrier uncouples the needle hub; and establishing a fluidic connection between the cannula and the fluid pathway; and responsive to the contacting: supplying, by the electronic circuit, a signal to a pressurization system of a non -sterile assembly; generating, by the pressurization system, a pressurizing gas based on the signal, wherein the pressurizing gas forces the sterile biologic from the drug container through the fluid path and the cannula into the patient. 2 . The method of claim 1 , wherein the pressurization system contains one or more hydrogen generators; wherein the one or more hydrogen generators generate the pressurizing gas in proportion to the signal supplied by the electronic circuit; and wherein the electronic circuit: determines the signal to obtain a desired flow rate of sterile biologic based upon a user flow control switch. 3 . The method of claim 1 , wherein the sterilized assembly further includes a drug viewing window; and wherein the drug viewing window enables the patient to view the drug container. 4 . The method of claim 1 , further comprising: removing, by the patient, a removable safety prior to the pushing of the start button, wherein the removable safety inhibits the patient from pressing the start button unless the removable safety is removed. 5 . The method of claim 1 , further comprising: displaying, by one or more visual indicators of the sterile assembly, one or more indications of an operational status of the electronic circuit board. 6 . The method of claim 1 , further comprising: affixing, by the patient, a base of a combined assembly to the patient, wherein the base of the combined assembly is made of a material with a low thermal conductivity and the combined assembly includes the sterile assembly and the non-sterile assembly. 7 . The method of claim 1 , further comprising: storing in a memory of the electronic circuit a time and a date when the patient administered the biologic. 8 . The method of claim 1 , further comprising: monitoring, by a pressure sensor, a pressure in the drug container; and determining, by the electronic circuit, the signal based on the pressure sensor. 9 . The method of claim 1 , wherein further responsive to the pushing, concurrently: locking the carrier in a position so that the cannula is held in position by a mechanical force in addition to a force provided by the primary spring; and locking the start button so that it cannot be pressed again. 10 . The method of claim 1 , further comprising: affixing, by the patient, an adhesive liner of a combined assembly to the patient, wherein the combined assembly includes the sterile assembly and the non-sterile assembly.
with needle insertion means · CPC title
with movable piercing means, e.g. ampoule remains fixed or steady · CPC title
with incorporated reservoirs · CPC title
pressurised by gas {introduced into the reservoir} · CPC title
the piston being actuated by fluid pressure · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.